Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the lewis lung carcinoma in nude mice.

Comparison of the selective targeting efficacy of Salmonella typhimurium A1-R and VNP20009 on the lewis lung carcinoma in nude mice.
Oncotarget. 2015 Jan 21;
Authors: Zhang Y, Zhang N, Hoffman RM, Zhao M
Abstract
Salmonella typhimurium A1-R is auxotrophic for arg and leu, which attenuates growth in normal tissue but allows high tumor targeting and virulence. A1-R is effective against metastatic human prostate, breast, and pancreatic cancer as well as osteosarcoma, fibrosarcoma, and glioma in clinically-relevant mouse models. VNP20009 is also a genetically-modified strain of Salmonella typhimurium that has been tested in Phase I clinical trials, but is more attenuated than S. typhimurium A1-R and in addition of multiple amino-acid auxotrophs, is purine auxotropic with the purI mutation. In the present study, mouse Lewis lung carcinoma-bearing nude mouse models were treated with S. typhimurium A1-R or VNP20009. S. typhimurium A1-R and VNP20009 were both eliminated from the liver and spleen approximately 3-5 days after administration via the tail vein. However, A1-R showed higher tumor targeting and inhibited the Lewis lung carcinoma to a greater extent than VNP20009, with less body weight loss. The mice tolerated S. typhimurium A1-R to at a least 2-fold higher dose than VNP20009 when the bacteria were administered iv. The results of the present study suggest that S. typhimurium A1-R has greater clinical potential than VNP20009.
...

Source: Oncotarget - February 28, 2015 Category: Cancer & Oncology Tags: Oncotarget Source Type: research